Lacey David L. 4
4 · Arcus Biosciences, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Lacey David L.
Director
Transactions
- Award
Common Stock
2023-06-15+6,800→ 49,252 total - Award
Stock Option (Right to Buy)
2023-06-15+19,500→ 19,500 totalExercise: $19.60Exp: 2033-06-14→ Common Stock (19,500 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.